FULL POSTER SESSION ABSTRACTSnumber of LysM domains, which are carbohydrate-binding modules. Ecp6, secreted by tomato leaf mould fungus Cladosporium fulvum, is the firstcharacterized LysM effector. We demonstrated that Ecp6 specifically binds chitin, the major constituent of fungal cell walls that acts as a microbialassociatedmolecular pattern (MAMP) and triggers immune responses upon recognition by the host. Ecp6 outcompetes plant receptors for chitin binding,and thus prevents the activation of immune responses. Many fungal genomes, including saprophytes, carry multiple LysM effector genes that share onlylow sequence conservation and encode a varying number of LysM domains. We speculate that fungal LysM effectors might bind different carbohydratesand exert various functions in fungal fitness. In the fungal wheat pathogen Mycosphaerella graminicola, two LysM effectors were identified. Mg3LysM, butnot Mg1LysM, suppresses chitin-induced immune responses in a similar fashion as Ecp6. Interestingly, unlike Ecp6, both Mg1LysM and Mg3LysM inhibitdegradation of fungal hyphae by plant chitinases, revealing an additional function for LysM effectors in pathogen virulence. We recently observed thatMg1LysM binds to the bacterial cell wall constituent peptidoglycan. Similarly, a LysM effector from the saprophytic fungus Neurospora crassa showedpeptidoglycan binding. We hypothesize that peptidoglycan binding by LysM effectors plays a role in the interaction of fungal species with bacterialcompetitors. The soil-borne fungal pathogen Verticillium dahliae contains seven LysM effectors genes of which one (Vd2LysM) is induced during tomatoinfection. Inoculation with two independent knock-out mutants revealed that Vd2LysM is required for full virulence of V. dahliae. However, Vd2LysM doesnot specifically bind chitin and does not function in a similar fashion as previous characterized LysM effectors. Thus, its function in virulence remainsunclear.523. WITHDRAWN524. Functional analysis and localization of SnTox1, a necrotrophic effector produced by the wheat pathogen Stagonospora nodorum. Zhaohui Liu 1 ,Weilin Shelver 2 , Justin Faris 3 , Timothy Friesen 1,3 . 1) Department of Plant Pathology, North Dakota State University, Fargo, ND; 2) USDA-ARS, BiosciencesResearch Laboratory, Fargo, ND; 3) USDA-ARS, Northern Crop Science Laboratory, Fargo, ND.SnTox1 is one of the necrotrophic effectors produced by the fungus Stagonospora nodorum, the causal agent of wheat Stagonospora nodorum blotch. Itinteracts, directly or indirectly, with the product of the wheat gene Snn1 to induce host cell death and promote disease. Previously, we showed thatSnTox1, a cysteine-rich protein, triggers programmed cell death-like responses in the host and plays an important role in fungal penetration. In the presentwork, we are investigating the biochemical and molecular function of SnTox1 as well as its mode of action. Based on a Prosite motif search of SnTox1,multiple predicted sites including a putative chitin binding domain were targeted for site-directed mutagenesis. SnTox1 activity was significantly reducedwhen mutations were produced at a casein kinase II phosphorylation site and a predicted helical region where lysine residues are abundant.Using a fungalstrain expressing an SnTox1-GFP fusion protein, we examined the location of the SnTox1 protein during fungal growth and infection. SnTox1 was observedin higher concentration on several fungal structures, including the surface of conidia and mycelium, hyphal septa, and hyphal tips. The accumulation ofSnTox1-GFP is particularly obvious at hyphal regions where new hyphae are arising. This observation suggests a protection mechanism of SnTox1 that issimilar to that of chitin binding proteins in other fungal pathogens. In planta, SnTox1 is highly expressed in the hyphopodia where the penetration isinitiated, providing further evidence that SnTox1 plays a role in penetration. The cellular localization of SnTox1 was also investigated using fluorescinelabeled SnTox1 in combination with cytological methods and preliminary data has indicated that SnTox1is likely not internalized into mesophyll cells butremains in the apoplast. Interestingly, SnTox1 is able to induce host cell death by directly spraying onto the leaf surface of sensitive lines. We are currentlyinvestigating if SnTox1 is transported through epidermal cell layer.525. Host-targeting protein 3 (SpHtp3) from the oomycete Saprolegnia parasitica translocates specifically into fish cells in a pH and tyrosine O-sulfatedependentmanner. Lars Löbach 1* , Stephan Wawra 2 , Irene de Bruijn 2 , Aleksandra Toloczko 2 , Tim Rasmussen 3 , Christopher Secombes 1 , Pieter van West 2 . 1)Scottish Fish Immunology Research Centre, University of Aberdeen, School of Biological Sciences, Aberdeen, Scotland, UK; 2) Aberdeen OomyceteLaboratory, University of Aberdeen, School of Medical Sciences, Foresterhill, Aberdeen, Scotland, UK; 3) University of Aberdeen, School of MedicalSciences, Foresterhill, Aberdeen, Scotland, UK.The success of eukaryotic oomycete pathogens depends largely on effector proteins, molecules which manipulate or interfere with host defencemechanisms in the extracellular space or inside their host cells. One economical important oomycete parasite is the fish pathogen Saprolegnia parasitica,which is the causal agent of the disease Saprolegniosis. S. parasitica is responsible for devastating losses in the aquaculture industry worldwide. In order toeffectively fight any pathogen it is crucial to understand the key molecular mechanisms that lead to the disease. With the focus on putative effectorproteins we screened the genome of S. parasitica in the present study for potential effector candidates. Analysis identified a novel putative secreted S.parasitica effector protein, which we named host-targeting protein 3 (SpHtp3). Gene expression analyses showed that mRNA levels of SpHtp3 are highestin mycelium, sporulating mycelium and during the later stages of infection. Recombinant SpHtp3 was able to translocate specifically into fish cells in atyrosine O-sulfate and pH dependent manner. SpHtp3 was found in vesicular structures inside fish cells and was released from these upon infection of thecells with S. parasitica. Interestingly, SpHtp3 possesses an N-terminal RTLR tetra-peptide sequence at a similar location as found in RxLR-effectors fromplant pathogenic oomycetes. However, this RTLR-sequence was not required for the fish cell translocation property of SpHtp3. These findings suggest thatSpHtp3 from S. parasitica is a novel intracellular protein that might play an important role in Saprolegniosis.526. Ave1-like orthologs in Venturia: another expanded effector family emerges. Adam Taranto 1 , Daniel Jones 1 , Jason Shiller 1 , Shakira Johnson 1 , NathanHall 1 , Ira Cooke 1 , Gert Talbo 1 , Carl Mesarich 2 , Bart Thomma 2 , Jordi Boshoven 2 , Joanna Bowen 3 , Cecilia Deng 3 , Matthew Templeton 3 , Kim M. Plummer 1 . 1)Dept Botany, La Trobe Univ, Melbourne, Victoria, Australia; 2) Laboratory of Phytopathology, Wageningen University, The Netherlands; 3) Plant & FoodResearch, Auckland, New Zealand.Effectors are secreted by pathogens to modify plant physiology and establish disease. Plant immune receptors have evolved to recognise effectors andcounter attack with defence responses. Most fungal effectors are lineage-specific, i.e. they are unique to a species, or to physiological races within aspecies. The availability of many whole genome sequences has revealed that some effectors are found in a discontinuous distribution within the fungalkingdom; a few phytopathogenic fungi (Colletotrichum higginsianum, Cercospora beticola, Fusarium oxysporum) possess an ortholog of Ave1 fromVerticillium dahliae, an effector that activates Ve1-mediated resistance in tomato. A subset of these orthologs were shown to activate Ve1-mediatedresistance in tomato. Unusually, Ave1 also shares similarity to an ortholog in the phytopathogenic bacterium Xanthomonas axonopodis, as well as to awidespread family of plant natriuretic peptides and expansins, involved in plant homeostasis and plant cell wall modification (de Jonge & van Esse et al.2012). We have identified an expanded Ave1-like gene family in apple and pear scab fungi, Venturia inaequalis and V. pirina. These species also haveexpanded gene families with similarity to the Leptosphaeria maculans effector AvrLm6. V. pirina has 14 unique hits (best,1.43e -18 ) to VdAve1. V. inaequalishas 17 unique hits (best,1.07e -22 ) to VdAve1. The distribution of Ave1 orthologs is suggestive of one or more cross-kingdom gene transfer events. We arecharacterising Venturia Ave1-like genes to investigate the mode of gene multiplication; seek evidence of horizontal gene transfer; and determine the role250
FULL POSTER SESSION ABSTRACTSof Ave1-like genes in pathogenicity. Ave1-like genes from non-Venturia fungi (and the bacterial gene) do not contain predicted introns, however, several(not all) V. inaequalis Ave1-like genes are predicted to contain introns. Codon usage bias among fungal, plant, and bacterial Ave1 orthologs, are beingcompared with the aim of inferring the kingdom of origin of the Venturia Ave1 orthologs. At least two ViAve1 orthologs are up-regulated during infectionof apple. To determine whether the Venturia Ave1 proteins also activate a Ve1-mediated hypersensitive response, each has been co-expressed withtomato Ve1 in Nicotiana tabacum, using an Agrobacterium tumefaciens-mediated transient transformation assay.527. Identification of targets of mycorrhizal effector proteins in planta. Natalia Requena, Carolin Heck, Ruben Betz. Molecular Phytopathology, KarlsruheInstitute of Technology, Karlsruhe, Germany.Plant roots are constantly approached by a myriad of microorganisms and are thus challenged to recognize friends from foes. Most plant roots engage ina mutualistic association with fungi from the Glomeromycota Phylum forming the arbuscular mycorrhiza (AM) symbiosis. The establishment of thisbeneficial association requires an intensive signal exchange including the down-regulation of PAMP triggered responses. We have shown that secretionand delivery of the effector proteins contribute to the manipulation of the plant defense response. In a previous work we showed that one of this proteinstravels to the plant nucleus and interacts with a plant transcription factor to down-regulate plant defenses. In order to identify further mechanisms of howsymbiotic effectors function we are investigating new plant targets of mycorrhizal effector proteins and how do they differ from targets from pathogenicfungi. Progress in this area will be presented.528. Structural basis for interactions of the Phytophthora sojae RXLR effector Avh5 with phosphatidylinositol 3-phosphate and for host cell entry.Furong Sun 2,3 , Shiv Kale 4 , Hugo Azurmendi 3 , Dan Li 2 , Brett M. Tyler 1,4 , Daniel Capelluto 2 . 1) Center for Genome Research and Biocomputing, Oregon StateUniversity, Corvallis, OR; 2) Dept of Biological Sciences, Virginia Tech, Blacksburg, VA 24061; 3) Dept of Chemistry, Virginia Tech, Blacksburg, VA 24061; 4)Virginia Bioinformatics Institute, Virginia Tech, Blacksburg, VA 24061.Oomycetes, such as Phytophthora sojae, employ protein effectors that enter host cells to facilitate infection. Entry of some effector proteins into plantcells is mediated by conserved RxLR motifs in the effectors and phosphoinositides (PIPs) resident in the host plasma membrane such asphosphatidylinositol 3-phosphate (PtdIns(3)P). Recent reports differ regarding the regions on RxLR effector proteins involved in PIP recognition. To clarifythese differences, we have structurally and functionally characterized the P. sojae effector, avirulence homolog-5 (Avh5). Using NMR spectroscopy, wedemonstrate that Avh5 is helical in nature with a long N-terminal disordered region. Heteronuclear single quantum coherence titrations of Avh5 with thePtdIns(3)P head group, inositol 1,3-bisphosphate (Ins(1,3)P2), allowed us to identify a C-terminal lysine-rich helical region (helix 2) as the principal lipidbindingsite in the protein, with the N-terminal RxLR (RFLR) motif playing a more minor role. Mutations in the RFLR motif slightly affected PtdIns(3)Pbinding, while mutations in the basic helix almost abolished it. Avh5 exhibited moderate affinity for PtdIns(3)P, which increased the thermal stability of theprotein. Mutations in the RFLR motif or in the basic region of Avh5 both significantly reduced protein entry into plant and human cells. Both regionsindependently mediated cell entry via a PtdIns(3)P-dependent mechanism. Our findings support a model in which Avh5 transiently interacts withPtdIns(3)P by specific electrostatic interactions mainly through its positively charged helix 2 region, enabling the RFLR domain to promote PI3P-mediatedhost entry. This study, including the identification of the PtdIns(3)P-binding site, provides an improved and updated model for how RxLR effector proteinsrecognize phosphoinositides and for the contributions of the RxLR motif and basic-rich C-terminal regions to the internalization process.529. Dose-dependent induction of plant immunity by application of the Fusarium mycotoxin deoxynivalenol. Antje Blümke, Christian A. Voigt. MolecularPhytopathology, Biocenter Klein Flottbek, Hamburg, Germany.The mycotoxin deoxynivalenol (DON) is associated with Fusarium head blight (FHB). This disease causes vast losses by reducing grain quantity andquality. Our study was aimed at analyzing cell wall changes in the host model grass Brachypodium distachyon due to infection with different F.graminearum mutants. The mutants vary in their ability to infect spikelets and to produce DON. As a reference, we used a F. graminearum wild-type strainwith the full capacity to produce DON and to cause FHB. The results were compared to the infection with the Dtri5, the Dfgl1, and the Dgpmk1 mutant.The Dtri5 mutant cannot produce DON due to disruption of the DON biosynthetic pathway. This mutant infects the directly inoculated spikelet withoutfurther propagation into the head tissue. A similar disease phenotype is described for the lipase-disruption mutant Dfgl1, which is able to produce DON.The MAP kinase disruption mutant Dgpmk1 is apathogenic but still able to produce DON. We observed similar disease phenotypes and amounts of DONfor all F. graminearum mutants during B. distachyon infection as described for wheat. 7 days post-inoculation (dpi), we analyzed the non-cellulosicmonocarbohydrate cell wall composition of B. distachyon spikelets by high-performance anion exchange chromatography with pulsed amperometricdetection (HPAEC-PAD). Only the infection with F. graminearum mutants that showed reduced virulence but still produce DON, namely the Dfgl1 andDgpmk1 mutants, resulted in compositional changes of the cell wall, an increase in the amount of glucose. Next, we wanted to know to what extend themycotoxin DON itself can induce cell wall changes. We applied DON solutions at different concentrations to B. distachyon spikelets. 7 dpi, the HPAEC-PADanalysis revealed an increase in the glucose amount only at relatively low DON concentrations of 1, 10, 100, and 1000 ppb whereas higher DONconcentrations of 50 and 100 ppm did not change the cell wall composition. However, only these high DON concentrations caused necrosis of florets.Interestingly, F. graminearum wild-type infection was significantly reduced on spikelets sprayed with a DON solution at a concentration of 1000 ppb 7 daysprior fungal inoculation. This suggests that the mycotoxin DON can induce an effector-triggered-like immunity in a dose-dependent manner.530. How Oomycete Pathogens Exploit PI3P to Target Secreted RxLR Effectors into Host Cells. Q. Wang 1 , S. Ferrer 1 , J. Carlough 1 , F. Arredondo 1 , S. Kale 2 ,B. Tyler 1 . 1) Botany and Plant Pathology, OREGON STATE UNIVERSITY, Corvallis, OR. 97330; 2) Virginia Bioinformatics Institute, Virginia Tech, Blacksburg,VA 24060.Effector proteins from diverse oomycetes and fungi can enter plant cells to facilitate infection. Recent research suggests that phosphoinositides (PIPs)resident in the host plasma membrane such as phosphatidylinositol 3-phosphate (PI3P) mediate the entry of some oomycete RxLR effectors. The PIPrecognition domain of these effectors is still controversial. Current evidence shows that either the RxLR domain or positive residues in the C-terminaldomains (Ct) of some effectors such as the P. sojae effectors Avr1b and Avh5 can bind PI3P, it has been unresolved which of these domains, if either, orboth, are involved in cell entry during natural pathogen infection. Here we have used heterologous PI3P-binding proteins, such as the yeast VAM7p PXdomain to replace the RxLR or Ct domains of Avr1b in P.sojae transformants. Our results reveal that the VAM7p PX domain can replace the RxLR domain ofAvr1b in carrying the C-terminal domain of Avr1b into soybean cells, conferring an avirulent phenotype on the transformants. Mutations that abolish thebinding of VAM7p to PI3P substantially reduce but do abolish avirulence conferred by the construct. Mutations in the PI3P-binding residues of the Avr1b Ctalso substantially reduce avirulence, while the double mutant cannot confer avirulence at all. These results strongly support the hypothesis that PI3Pbindingis essential for Avr1b cell entry during natural infection, and further suggest that efficient entry by Avr1b may require two PI3P binding sites.<strong>27th</strong> <strong>Fungal</strong> <strong>Genetics</strong> <strong>Conference</strong> | 251
- Page 1:
Asilomar Conference GroundsMarch 12
- Page 7 and 8:
SCHEDULE OF EVENTSFriday, March 157
- Page 10 and 11:
EXHIBITSThe following companies hav
- Page 12 and 13:
CONCURRENT SESSIONS SCHEDULESWednes
- Page 14:
CONCURRENT SESSIONS SCHEDULESWednes
- Page 17 and 18:
CONCURRENT SESSIONS SCHEDULESThursd
- Page 19:
CONCURRENT SESSIONS SCHEDULESFriday
- Page 22 and 23:
CONCURRENT SESSIONS SCHEDULESSaturd
- Page 24:
CONCURRENT SESSIONS SCHEDULESSaturd
- Page 27 and 28:
PLENARY SESSION ABSTRACTSThursday,
- Page 29 and 30:
PLENARY SESSION ABSTRACTSFriday, Ma
- Page 31 and 32:
PLENARY SESSION ABSTRACTSSaturday,
- Page 33 and 34:
CONCURRENT SESSION ABSTRACTSWednesd
- Page 35 and 36:
CONCURRENT SESSION ABSTRACTSUnravel
- Page 37 and 38:
CONCURRENT SESSION ABSTRACTSSynergi
- Page 39 and 40:
CONCURRENT SESSION ABSTRACTSWednesd
- Page 41 and 42:
CONCURRENT SESSION ABSTRACTSWednesd
- Page 43 and 44:
CONCURRENT SESSION ABSTRACTSWednesd
- Page 45 and 46:
CONCURRENT SESSION ABSTRACTSA draft
- Page 47 and 48:
CONCURRENT SESSION ABSTRACTSRegulat
- Page 49 and 50:
CONCURRENT SESSION ABSTRACTSWednesd
- Page 51 and 52:
CONCURRENT SESSION ABSTRACTSThursda
- Page 53 and 54:
CONCURRENT SESSION ABSTRACTSThursda
- Page 55 and 56:
CONCURRENT SESSION ABSTRACTSThursda
- Page 57 and 58:
CONCURRENT SESSION ABSTRACTSThursda
- Page 59 and 60:
CONCURRENT SESSION ABSTRACTSThursda
- Page 61 and 62:
CONCURRENT SESSION ABSTRACTSThe mut
- Page 63 and 64:
CONCURRENT SESSION ABSTRACTSInnate
- Page 65 and 66:
CONCURRENT SESSION ABSTRACTSThursda
- Page 67 and 68:
CONCURRENT SESSION ABSTRACTSGenome-
- Page 69 and 70:
CONCURRENT SESSION ABSTRACTSIdentif
- Page 71 and 72:
CONCURRENT SESSION ABSTRACTSFriday,
- Page 73 and 74:
CONCURRENT SESSION ABSTRACTSFriday,
- Page 75 and 76:
CONCURRENT SESSION ABSTRACTSThe Scl
- Page 77 and 78:
CONCURRENT SESSION ABSTRACTSThe rol
- Page 79 and 80:
CONCURRENT SESSION ABSTRACTSFriday,
- Page 81 and 82:
CONCURRENT SESSION ABSTRACTSCompari
- Page 83 and 84:
CONCURRENT SESSION ABSTRACTSNovel t
- Page 85 and 86:
CONCURRENT SESSION ABSTRACTSFriday,
- Page 87 and 88:
CONCURRENT SESSION ABSTRACTSEffect
- Page 89 and 90:
CONCURRENT SESSION ABSTRACTSCommon
- Page 91 and 92:
CONCURRENT SESSION ABSTRACTSSaturda
- Page 93 and 94:
CONCURRENT SESSION ABSTRACTSSeconda
- Page 95 and 96:
CONCURRENT SESSION ABSTRACTSSheddin
- Page 97 and 98:
CONCURRENT SESSION ABSTRACTSSaturda
- Page 99 and 100:
CONCURRENT SESSION ABSTRACTSSaturda
- Page 101 and 102:
CONCURRENT SESSION ABSTRACTSSaturda
- Page 103 and 104:
CONCURRENT SESSION ABSTRACTSprocess
- Page 105 and 106:
CONCURRENT SESSION ABSTRACTSSpecifi
- Page 107 and 108:
LISTING OF ALL POSTER ABSTRACTSBioc
- Page 109 and 110:
LISTING OF ALL POSTER ABSTRACTS81.
- Page 111 and 112:
LISTING OF ALL POSTER ABSTRACTS160.
- Page 113 and 114:
LISTING OF ALL POSTER ABSTRACTS239.
- Page 115 and 116:
LISTING OF ALL POSTER ABSTRACTS322.
- Page 117 and 118:
LISTING OF ALL POSTER ABSTRACTS401.
- Page 119 and 120:
LISTING OF ALL POSTER ABSTRACTSmedi
- Page 121 and 122:
LISTING OF ALL POSTER ABSTRACTS558.
- Page 123 and 124:
LISTING OF ALL POSTER ABSTRACTS640.
- Page 125 and 126:
LISTING OF ALL POSTER ABSTRACTS723.
- Page 127 and 128:
FULL POSTER SESSION ABSTRACTS5. Cha
- Page 129 and 130:
FULL POSTER SESSION ABSTRACTS13. In
- Page 131 and 132:
FULL POSTER SESSION ABSTRACTSbioche
- Page 133 and 134:
FULL POSTER SESSION ABSTRACTS30. Me
- Page 135 and 136:
FULL POSTER SESSION ABSTRACTS38. Me
- Page 137 and 138:
FULL POSTER SESSION ABSTRACTSidenti
- Page 139 and 140:
FULL POSTER SESSION ABSTRACTSsecret
- Page 141 and 142:
FULL POSTER SESSION ABSTRACTSinvolv
- Page 143 and 144:
FULL POSTER SESSION ABSTRACTSdiploi
- Page 145 and 146:
FULL POSTER SESSION ABSTRACTSSaccha
- Page 147 and 148:
FULL POSTER SESSION ABSTRACTSresist
- Page 149 and 150:
FULL POSTER SESSION ABSTRACTS96. Ce
- Page 151 and 152:
FULL POSTER SESSION ABSTRACTS104. M
- Page 153 and 154:
FULL POSTER SESSION ABSTRACTScan ex
- Page 155 and 156:
FULL POSTER SESSION ABSTRACTSturgor
- Page 157 and 158:
FULL POSTER SESSION ABSTRACTSlike p
- Page 159 and 160:
FULL POSTER SESSION ABSTRACTSIndoor
- Page 161 and 162:
FULL POSTER SESSION ABSTRACTSlength
- Page 163 and 164:
FULL POSTER SESSION ABSTRACTSA scre
- Page 165 and 166:
FULL POSTER SESSION ABSTRACTSthen q
- Page 167 and 168:
FULL POSTER SESSION ABSTRACTS170. S
- Page 169 and 170:
FULL POSTER SESSION ABSTRACTSof sup
- Page 171 and 172:
FULL POSTER SESSION ABSTRACTSis fzo
- Page 173 and 174:
FULL POSTER SESSION ABSTRACTSgrowth
- Page 175 and 176:
FULL POSTER SESSION ABSTRACTSSeq da
- Page 177 and 178:
FULL POSTER SESSION ABSTRACTS212. T
- Page 179 and 180:
FULL POSTER SESSION ABSTRACTSCompar
- Page 181 and 182:
FULL POSTER SESSION ABSTRACTSmore g
- Page 183 and 184:
FULL POSTER SESSION ABSTRACTSmolecu
- Page 185 and 186:
FULL POSTER SESSION ABSTRACTSunexpe
- Page 187 and 188:
FULL POSTER SESSION ABSTRACTSrapid
- Page 189 and 190:
FULL POSTER SESSION ABSTRACTS260. T
- Page 191 and 192:
FULL POSTER SESSION ABSTRACTSFusari
- Page 193 and 194:
FULL POSTER SESSION ABSTRACTSScienc
- Page 195 and 196:
FULL POSTER SESSION ABSTRACTS286. G
- Page 197 and 198:
FULL POSTER SESSION ABSTRACTSincomp
- Page 199 and 200:
FULL POSTER SESSION ABSTRACTSfound
- Page 201 and 202:
FULL POSTER SESSION ABSTRACTS312. I
- Page 203 and 204: FULL POSTER SESSION ABSTRACTSall th
- Page 205 and 206: FULL POSTER SESSION ABSTRACTSPia La
- Page 207 and 208: FULL POSTER SESSION ABSTRACTS335. A
- Page 209 and 210: FULL POSTER SESSION ABSTRACTS342. F
- Page 211 and 212: FULL POSTER SESSION ABSTRACTSThis i
- Page 213 and 214: FULL POSTER SESSION ABSTRACTSJacobs
- Page 215 and 216: FULL POSTER SESSION ABSTRACTScalciu
- Page 217 and 218: FULL POSTER SESSION ABSTRACTSThe ab
- Page 219 and 220: FULL POSTER SESSION ABSTRACTSexpres
- Page 221 and 222: FULL POSTER SESSION ABSTRACTS394. F
- Page 223 and 224: FULL POSTER SESSION ABSTRACTS398. U
- Page 225 and 226: FULL POSTER SESSION ABSTRACTSthe id
- Page 227 and 228: FULL POSTER SESSION ABSTRACTS415. A
- Page 229 and 230: FULL POSTER SESSION ABSTRACTSAcuM b
- Page 231 and 232: FULL POSTER SESSION ABSTRACTSdiverg
- Page 233 and 234: FULL POSTER SESSION ABSTRACTSBck1 f
- Page 235 and 236: FULL POSTER SESSION ABSTRACTSin the
- Page 237 and 238: FULL POSTER SESSION ABSTRACTS455. T
- Page 239 and 240: FULL POSTER SESSION ABSTRACTSor hos
- Page 241 and 242: FULL POSTER SESSION ABSTRACTSfragme
- Page 243 and 244: FULL POSTER SESSION ABSTRACTSenhanc
- Page 245 and 246: FULL POSTER SESSION ABSTRACTSassess
- Page 247 and 248: FULL POSTER SESSION ABSTRACTSmating
- Page 249 and 250: FULL POSTER SESSION ABSTRACTScommon
- Page 251 and 252: FULL POSTER SESSION ABSTRACTSOne of
- Page 253: FULL POSTER SESSION ABSTRACTScells
- Page 257 and 258: FULL POSTER SESSION ABSTRACTSascaro
- Page 259 and 260: FULL POSTER SESSION ABSTRACTSis a n
- Page 261 and 262: FULL POSTER SESSION ABSTRACTSand th
- Page 263 and 264: FULL POSTER SESSION ABSTRACTSCiuffe
- Page 265 and 266: FULL POSTER SESSION ABSTRACTSon oth
- Page 267 and 268: FULL POSTER SESSION ABSTRACTScopies
- Page 269 and 270: FULL POSTER SESSION ABSTRACTSChem.
- Page 271 and 272: FULL POSTER SESSION ABSTRACTS593. C
- Page 273 and 274: FULL POSTER SESSION ABSTRACTS601. P
- Page 275 and 276: FULL POSTER SESSION ABSTRACTSE.elym
- Page 277 and 278: FULL POSTER SESSION ABSTRACTSThe de
- Page 279 and 280: FULL POSTER SESSION ABSTRACTSMicrob
- Page 281 and 282: FULL POSTER SESSION ABSTRACTSchromo
- Page 283 and 284: FULL POSTER SESSION ABSTRACTSmating
- Page 285 and 286: FULL POSTER SESSION ABSTRACTSAt the
- Page 287 and 288: FULL POSTER SESSION ABSTRACTSemerge
- Page 289 and 290: FULL POSTER SESSION ABSTRACTS666. G
- Page 291 and 292: FULL POSTER SESSION ABSTRACTSof che
- Page 293 and 294: FULL POSTER SESSION ABSTRACTSthe lo
- Page 295 and 296: FULL POSTER SESSION ABSTRACTSin the
- Page 297 and 298: FULL POSTER SESSION ABSTRACTSpotent
- Page 299 and 300: FULL POSTER SESSION ABSTRACTSpoint
- Page 301 and 302: FULL POSTER SESSION ABSTRACTS716. p
- Page 303 and 304: FULL POSTER SESSION ABSTRACTSnatura
- Page 305 and 306:
FULL POSTER SESSION ABSTRACTSelemen
- Page 307 and 308:
KEYWORD LISTABC proteins ..........
- Page 309 and 310:
KEYWORD LISThigh temperature growth
- Page 311 and 312:
AUTHOR LISTBolton, Melvin D. ......
- Page 313 and 314:
AUTHOR LISTFrancis, Martin ........
- Page 315 and 316:
AUTHOR LISTKawamoto, Susumu... 427,
- Page 317 and 318:
AUTHOR LISTNNadimi, Maryam ........
- Page 319 and 320:
AUTHOR LISTSenftleben, Dominik ....
- Page 321 and 322:
AUTHOR LISTYablonowski, Jacob .....
- Page 323 and 324:
LIST OF PARTICIPANTSLeslie G Beresf
- Page 325 and 326:
LIST OF PARTICIPANTSTim A DahlmannR
- Page 327 and 328:
LIST OF PARTICIPANTSIgor V Grigorie
- Page 329 and 330:
LIST OF PARTICIPANTSMasayuki KameiT
- Page 331 and 332:
LIST OF PARTICIPANTSGeorgiana MayUn
- Page 333 and 334:
LIST OF PARTICIPANTSNadia PontsINRA
- Page 335 and 336:
LIST OF PARTICIPANTSFrancis SmetUni
- Page 337 and 338:
LIST OF PARTICIPANTSAric E WiestUni